Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Doccole on Jun 15, 2022 7:13am

Warrant extension

What will this mean for the stock price? 


What / if any significance does this news bring?

thanks for thoughts!

Comment by MrMugsy on Jun 15, 2022 7:56am
Renegotiated pricing on the warrant in order to still be able to bring in some cash before 2024.  Probably wise to have that stream of cash available as ATE will be burning through cash. The potential expiration of of the June warrants wasn't doing anything to prop up the share price so I wouldn't think it will have any effect the other way either.  Guessing it's neutral ...more  
Comment by StockingUp21 on Jun 15, 2022 9:28am
Mayne look at other businesses that have done the same thing. If I had a guess...
Comment by Doccole on Jun 15, 2022 9:58am
If our stock price is 1.80 in 2023, fail. I am hoping for more than that.  i am hoping for a big rebound going into phase 2 with some progress updates.
Comment by Mmmtroll on Jun 15, 2022 4:01pm
realistically the price is gonna have to be 2.25+ for anyone considering their warrants.
Comment by MrMugsy on Jun 15, 2022 5:34pm
Right!  Was thinking >3 with reasonable volume for the stock.
Comment by Mmmtroll on Jun 15, 2022 9:42pm
you guys aren't using Dumbo Dan logic though. If they drop the warrant price then, they will get exercised. Which means antibe gets a bonus 5m. But what it really gives them the ability to do is to dilute even further should the price continue upwards. Classic move.
Comment by MrMugsy on Jun 16, 2022 7:56am
Potential cash from future warrants if exercised ... 1.  Feb 24, 2023 - $2,400,000 2.  Dec 31, 2023 - $5,600,000 (modified) 3.  Feb 24, 2024 - $25,200,000 Over $33,000,000 in cash available if warrants fully exercised (without further modification). Does that sound right ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities